Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Mapping the KRAS Proteoform in Colorectal Cancer - MagLab
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations | Journal of Proteome Research
Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer | PNAS
The mutation distribution of KRAS/NRAS/BRAF in (A) colon cancer, (B)... | Download Scientific Diagram
APMG Colon Molecular Pathways
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Personalized Cancer Treatment and the Myth of KRAS Wild-type Colon Tumors - Barbara L Parsons - Discovery Medicine
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
The Trouble With KRAS - Cancer Commons
KRAS Biomarker | Colorectal Cancer Alliance
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Targeting EGFR in metastatic colorectal cancer beyond the limitations of KRAS status: alternative biomarkers and therapeutic strategies | Biomarkers in Medicine
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
